Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

A Personalized Clinical-Decision Tool to Improve the Diagnostic Accuracy of Myelodysplastic Syndromes

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-139412

Published: 2020

Journal Articles

Genotype-Phenotype Correlations in Patients with Myeloid Malignancies Using Explainable Artificial Intelligence

Nathan Radakovich, BA, Luca Malcovati, MD, Manja Meggendorfer, PhD, Mikkael A. Sekeres, MD MS, Jacob Shreve, MD MS, Cameron Beau Hilton, MD, Yazan Rouphail, Wencke Walter, PhD, Stephan Hutter, PhD, Anna Gallì, Sarah Pozzi, Aaron T. Gerds, MDMS, Sudipto Mukherjee, MD PhD MPH, Cassandra M Kerr, MS, Babal K. Jha, PhD, Claudia Haferlach, MD, Jaroslaw P. Maciejewski, MD PhD, Torsten Haferlach, MD, Aziz Nazha, MD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-140023

Published: 2020

Journal Articles

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Stefania Bregante, Alida Dominietto, MD, Anna Ghiso, Anna Maria Raiola, Francesca Gualandi, MD, Riccardo Varaldo, Carmen Di Grazia, MD, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Lucia Casarino, Sarah Pozzi, Elisabetta Tedone, Maria Teresa van Lint, MD, Federica Galaverna, Gianni Barosi, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 4336.

https://doi.org/10.1182/blood.V126.23.4336.4336

Published: 2015

Journal Articles

The Impact of Driver Mutations of JAK2, Calr , or MPL in Patients with Myelofibrosis Undergoing Hemopoietic Stem Cell Transplantation

Andrea Bacigalupo, MD, Sarah Pozzi, Maria Teresa van Lint, MD, Stefania Bregante, Gianni Barosi, Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, Mario Cazzola, MD

Blood (2015) 126 (23): 5405.

https://doi.org/10.1182/blood.V126.23.5405.5405

Published: 2015

Journal Articles

CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation

Alessandra Stasia, MD, Anna Ghiso, Anna Maria Raiola, Federica Galaverna, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, Sarah Pozzi, Silvia Luchetti, Enrico Maria Pogliani, MD, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 3306.

https://doi.org/10.1182/blood.V122.21.3306.3306

Published: 2013

Journal Articles

Transfusion Requirement, Spleen Size and Donor Type Are Strong Predictors of Outcome in Patients with Primary Myelofibrosis Undergoing an Allogeneic Stem Cell Transplant

Andrea P Bacigalupo, Alida Dominietto, Sarah Pozzi, Simona Geroldi, Maria Teresa van Lint, Anna Maria Raiola, Giovanni Barosi, MD

Blood (2012) 120 (21): 1725.

https://doi.org/10.1182/blood.V120.21.1725.1725

Published: 2012

Journal Articles

Iron Chelation Therapy and Mobilization of Hematopoietic Peripheral Progenitors in Patients with β-Thalassemia Major

Gian Luca Forni, MD, Marina Podestà, Marco Musso, Giovanna Piaggio, Khaled M Musallam, Manuela Balocco, Sarah Pozzi, Francesco Frassoni

Blood (2012) 120 (21): 5178.

https://doi.org/10.1182/blood.V120.21.5178.5178

Published: 2012

Journal Articles

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Blood (2009) 114 (14): 3127–3130.

https://doi.org/10.1182/blood-2008-12-190991

Published: 2009

Journal Articles

A High Sensitivity Detection Technique Reveals JAK2-V617F Mutation in Additional 20% of Patients with Essential Thrombocytemia, but Not in Patients with Primary Myelofibrosis, Considered Negative with a Conventional ASO-PCR

Francesca Bertolotti, PhD, Sarah Pozzi, PhD, Massimo Ulivi, PhD, Marina Podestà, BiolSci, Davide Imperiale, Vittorio Rosti, MD, Francesco Frassoni, MD

Blood (2008) 112 (11): 2801.

https://doi.org/10.1182/blood.V112.11.2801.2801

Published: 2008

Journal Articles

Modulated Expression of BCL-xL and GATA-1 Genes Is a Common Feature in Myeloproliferative Disorders (MPD) Both in JAK2-V617F Positive and Negative Patients

Sarah Pozzi, BSC, Francesca Bertolotti, BSC, Silvio Parodi, MD, Raffaella Ponassi, BSC, Barbara Biasotti, BSC, Silvia Bruno, BSC, Vittorio Rosti, MD, Alessia Parodi, BSC, Barbara Bruno, BSC, Davide Imperiale, Giovanna Piaggio, BSC, Marina Podestà, BSC, Andrea Gallamini, MD, Caterina Passalia, MD, Giovanni Barosi, MD, Francesco Frassoni, MD

Blood (2007) 110 (11): 1533.

https://doi.org/10.1182/blood.V110.11.1533.1533

Published: 2007

Journal Articles

Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.

Adalberto Ibatici, MD, AnnaMaria Raiola, MD, Marina Podesta, BSC, Francesca Gualandi, MD, Nadia Sessarego, BSC, Alessia Parodi, BSC, Silvia Luchetti, BSC, Sarah Pozzi, BSC, Valeria Pinto, MD, Giovanna Piaggio, BSC, Marco Gobbi, MD, Andrea Bacigalupo, MD, Francesco Frassoni, MD

Blood (2007) 110 (11): 334.

https://doi.org/10.1182/blood.V110.11.334.334

Published: 2007

Journal Articles

Allogeneic Hemopoietic Stem Transplant for Patients with Idiopathic Myelofibrosis Using a Reduced Intensity Thiotepa Based Conditioning Regimen.

Andrea Bacigalupo, MD, Alida Dominietto, MD, Sarah Pozzi, MD, Giovanna Piaggio, MD, Maria Teresa van Lint, MD, Simonetta Zupo, MD, Anna Maria Raiola, MD, Marco Gobbi, MD, Francesco Frassoni, MD, Francesco De Stefano, MD, Simonetta Verdiani, MD, Giovanni Barosi, MD

Blood (2007) 110 (11): 684.

https://doi.org/10.1182/blood.V110.11.684.684

Published: 2007

Journal Articles

Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia

Alida Dominietto, Sarah Pozzi, Maurizio Miglino, Flavio Albarracin, Giovanna Piaggio, Francesca Bertolotti, Raffaella Grasso, Simona Zupo, Anna Maria Raiola, Marco Gobbi, Francesco Frassoni, Andrea Bacigalupo

Blood (2007) 109 (11): 5063–5064.

https://doi.org/10.1182/blood-2007-02-072470

Published: 2007

Journal Articles

Direct Intra-Bone Marrow Transplant of Cord Blood Cells: A Way To Overcome Delayed Engraftment.

Adalberto Ibatici, Anna Maria Raiola, Marina Podesta, Sarah Pozzi, Silvia Lucchetti, Lucia Casarino, Domenico Occhini, Maria Teresa van Lint, Francesca Gualandi, Francesco Gamaleri, Andrea Bacigalupo, Francesco Frassoni

Blood (2006) 108 (11): 3190.

https://doi.org/10.1182/blood.V108.11.3190.3190

Published: 2006

Journal Articles

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT).

Alida Dominietto, MD, Giovanna Piaggio, MD, Sarah Pozzi, MD, Francesca Bertolotti, MD, Nicoletta Colombo, MD, Raffaella Grasso, MD, Anna Garuti, MD, Gabriella Cirmena, MD, Maurizio Miglino, MD, Anna Maria Raiola, MD, Maria Teresa van Lint, MD, Francesco Frassoni, MD, Marina Podesta’, MD, Andrea Bacigalupo, MD

Blood (2005) 106 (11): 2012.

https://doi.org/10.1182/blood.V106.11.2012.2012

Published: 2005

Journal Articles

Molecular Responders (<3-log Reduction) among CML Patients in Complete Cytogenetic Remission Show a Lower Number of BCR-ABL+ Hematopoietic Progenitors Compared to Non-Responders.

Adalberto Ibatici, Giusy Fugazza, Nadia Sessarego, Marina Podesta, Stefania Agliano, Sarah Pozzi, Mirko Corselli, Anna Garuti, Mario Sessarego, Francesco Frassoni

Blood (2005) 106 (11): 4325.

https://doi.org/10.1182/blood.V106.11.4325.4325

Published: 2005

Journal Articles

Rituximab Prophylaxis of EBV Reactivation after Unrelated Donor Transplants Using Anti-Thymocyte Globulin in the Conditioning Regimen.

Andrea Bacigalupo, MD, Alida Dominietto, MD, Monica Soracco, MD, Sarah Pozzi, MD, Anna Maria Raiola, MD, Maria Teresa van Lint, MD, Teresa Lamparelli, MD, Adalberto Ibatici, MD, Francesco Frassoni, MD, Elisabetta Tedone, MD

Blood (2005) 106 (11): 3231.

https://doi.org/10.1182/blood.V106.11.3231.3231

Published: 2005

Journal Articles

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Anna Garuti, PhD, Adalberto Ibatici, MD, Gabriella Cirmena, PhD, Maurizio Miglino, MD, Riccardo Varaldo, MD, Colombo Nicoletta, PhD, Roberta Grasso, PhD, Sarah Pozzi, PhD, Marina Podesta, PhD, Marco Gobbi, MD, Mario Sessarego, MD, Franco Patrone, MD, Francesco Frassoni, MD

Blood (2005) 106 (11): 3282.

https://doi.org/10.1182/blood.V106.11.3282.3282

Published: 2005

Journal Articles

Interaction of Human Mesenchymal Stem Cells with Alloantigen-Induced T Lymphocyte Activation Favors the Differentiation of CD4 + T Cell Subsets Expressing CD25 and/or CTLA4 Molecules.

Rita Maccario, Ph.D., Marina Podestà, Ph.D., Antonia Moretta, Ph.D., Angela Cometa, Ph.D., Patrizia Comoli, M.D., Daniela Montagna, Ph.D., Adalberto Ibatici, M.D., Giovanna Piaggio, Ph.D., Sarah Pozzi, Ph.D., Francesco Frassoni, M.D., Franco Locatelli, M.D.

Blood (2004) 104 (11): 2123.

https://doi.org/10.1182/blood.V104.11.2123.2123

Published: 2004

Journal Articles

The Suppressive Effect of Bone Marrow Mesenchymal Stem Cells on T Cell Activation, Is Deficient in Patients with Severe Aplastic Anemia.

Andrea Bacigalupo, MD, Marisa Valle, BS, Marina Podesta’, BS, Anna Pitto, BS, Elena Zocchi, BS, Antonio De Flora, MD, Sarah Pozzi, BS, Franca Vassallo, BS, Silvia Lucchetti, BS, Osvaldo Figari, BS, Francesco Frassoni, MD, Giovanna Piaggio, BS

Blood (2004) 104 (11): 506.

https://doi.org/10.1182/blood.V104.11.506.506

Published: 2004

NARROW

A Personalized Clinical-Decision Tool to Improve the Diagnostic Accuracy of Myelodysplastic Syndromes

Genotype-Phenotype Correlations in Patients with Myeloid Malignancies Using Explainable Artificial Intelligence

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

The Impact of Driver Mutations of JAK2, Calr , or MPL in Patients with Myelofibrosis Undergoing Hemopoietic Stem Cell Transplantation

CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation

Transfusion Requirement, Spleen Size and Donor Type Are Strong Predictors of Outcome in Patients with Primary Myelofibrosis Undergoing an Allogeneic Stem Cell Transplant

Iron Chelation Therapy and Mobilization of Hematopoietic Peripheral Progenitors in Patients with β-Thalassemia Major

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

A High Sensitivity Detection Technique Reveals JAK2-V617F Mutation in Additional 20% of Patients with Essential Thrombocytemia, but Not in Patients with Primary Myelofibrosis, Considered Negative with a Conventional ASO-PCR

Modulated Expression of BCL-xL and GATA-1 Genes Is a Common Feature in Myeloproliferative Disorders (MPD) Both in JAK2-V617F Positive and Negative Patients

Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.

Allogeneic Hemopoietic Stem Transplant for Patients with Idiopathic Myelofibrosis Using a Reduced Intensity Thiotepa Based Conditioning Regimen.

Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia

Direct Intra-Bone Marrow Transplant of Cord Blood Cells: A Way To Overcome Delayed Engraftment.

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT).

Molecular Responders (<3-log Reduction) among CML Patients in Complete Cytogenetic Remission Show a Lower Number of BCR-ABL+ Hematopoietic Progenitors Compared to Non-Responders.

Rituximab Prophylaxis of EBV Reactivation after Unrelated Donor Transplants Using Anti-Thymocyte Globulin in the Conditioning Regimen.

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Interaction of Human Mesenchymal Stem Cells with Alloantigen-Induced T Lymphocyte Activation Favors the Differentiation of CD4 + T Cell Subsets Expressing CD25 and/or CTLA4 Molecules.

The Suppressive Effect of Bone Marrow Mesenchymal Stem Cells on T Cell Activation, Is Deficient in Patients with Severe Aplastic Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only